title: Treatment of relapsing-remitting multiple sclerosis:  current approaches and unmet needs.
abstract: OBJECTIVE
  The aim of this review is to summarize unmet needs for patients with multiple sclerosis (MS). It is important to understand the current status of these patients and both the benefits and limitations of the most commonly used MS treatments as new medications with the potential to simplify therapy and improve outcomes may soon be available.
  
  
  RESULTS
  Current treatments for MS decrease the frequency of relapses and slow progressive disability. However, nearly all of these medications require frequent administration, and some patients also experience side effects. In some patients, adherence to MS treatment may be less than optimal. This may be associated with increased risk for relapses and hospitalizations and higher cost of care.
  
  
  CONCLUSIONS
  Healthcare providers involved in the treatment of MS must be aware of the unmet needs of their patients and intervene as needed to improve adherence and/or modify treatment regimens to optimize outcomes.
authors.affiliation: Corinne Goldsmith Dikinson Center for Multiple Sclerosis, Mount Sinai School of Medicine, New York, New York 10029, USA. aaron.miller@mssm.edu
authors.forename: Aaron E
authors.initials: AE
authors.lastname: Miller
authors.forename: Robert W
authors.initials: RW
authors.lastname: Rhoades
mesh_terms: D006233:Persons with Disabilities; D018450:Disease Progression; D006301:Health Services Needs and Demand; D006801:Humans; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000191:economics / Q000453:epidemiology / Q000523:psychology / Q000628:therapy*; D010349:Patient Compliance